Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis

NCT03011281 is registered in ClinicalTrials.gov with Hanyang University as lead sponsor.

NCT NCT03011281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03011281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis
Lead sponsor
Hanyang University
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2021
Enrollment
378 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis